
Digital breast tomosynthesis
By Thomas Mertelmeier, Principal Scientist at Siemens AG Medical Solutions

By Thomas Mertelmeier, Principal Scientist at Siemens AG Medical Solutions

Congress President Professor Juergen Dunst MD praises major advances and multidisciplinary efforts, and outlines future hopes for breast cancer patients

Full field digital mammography (FFDM) and computed radiography (CR) based mammography systems may bring hospitals and breast imaging services closer to gaining digital mammography, but, according to a leading systems vendor, simply buying imaging equipment does not automatically lead to a more efficient workflow.

When equally compressed, the tissue and structure of tumours and inflammations are harder than normal tissue. Hitachi explains that, taking advantage of these alterations, the sono-elastography technique conducts real-time measurements of elasticity ratios during minor pressure to the breast, using conventional ultrasound transducers.

Italy — One of the biggest RIS/PACS implementations in Europe is being co-ordinated the Area Vasta Centro (AVC) group, which runs 12 hospitals in central Tuscany. Among these, CPA Pistoia hospital (one of three in the ASL 3 Pistoia group, a sub-division of AVC) is streamlining its mammography workflow with a CR Mammography system supplied by Agfa HealthCare.

In 2002, Germany implemented an early detection programme for breast cancer. The digital Reference Centre For Mammography at the University Hospital Münster is one of five such centres in the country - and it's one of the most modern, providing digital systems for imaging and results evaluation as well as a mammo-PACS.

In Ireland, breast cancer is particularly virulent: 18.5% of all cancer related deaths among the women are due to breast cancer.

2D imaging - whether analogue or digital - is thought to miss detection of 20-30% of breast cancers. Early clinical results from studies using the new technology tomosynthesis indicate its potential to lower those percentages.

This year´s congress of the German Society of Senology (June 21.-23. in Lübeck, Germany) will deal with latest developments in the diagnosis and therapy of breast cancer like screening and early detection methods or new diagnostic modalities.

The Swedish IT and medical-technology company Sectra, together with clinical and industrial partners from six European countries, has been awarded EUR 3.6 million from the European Union to combat breast cancer through a research project for high-resolution, low-dose X-ray imaging.

The use of computer-aided detection (CAD) with computed radiography (CR) is very effective in the detection of breast cancer according to a recent study at George Washington University Medical Center in Washington, DEC and iCAD in Nashua, NH.

Approximately 75 percent of all biopsies are negative, which is of course the good news. But looking at the side effects of this invasive method combined with a long waiting time for the results, a biopsy is nevertheless an unpleasant procedure for the women affected. A new promising technology now offers the possibility to differentiate benign and malignant tissue due to an adjunct of the…

The first highlight is the expansion of IMPAX 6, the globally successful web-based PACS for diagnostic mammography.

Targeted medication and gentle surgical procedures are the pillars of modern breast cancer therapy, according to participants at this years German Congress of Senology.

A report by Keith Halson, our correspondent in France.

Guidelines updated for high-risk women aged between 20-49 years.

At RSNA, Agfa HealthCare introduced a range of functional extensions for digital mammography reading and reporting applications on its industry leading IMPAX™ PACS platform. The company launched IMPAX 6.2 integrated with CAD and MRS® Reporting as well as showing a work-in-progress of a new software application that addresses the growing need for digital mammography screening.

An unparalleled legal challenge has been underway in the EU regarding the number of human gene patents held by US-based corporation Myriad Genetics.

Optical imaging stands on the threshold of a vast array of imaging uses, writes Professor Eric N C Milne MD FRCR FRCP, Professor Emeritus of Radiology and Medicine, University of California Irvine, and Director of Clinical Research, Imaging Diagnostic Systems Inc. `Presently, its greatest worth lies in higher sensitivity for the dense breast. It detects many more occult cancers than conventional…

USA - Radiologists at Newton-Wellesley Hospital in Newton, Massachusetts have released findings from a breast cancer research study designed to evaluate the use of software from Advanced Image Enhancement, Inc (AIE) for examining regions of interest (ROI) with Hologic's Lorad Selenia digital mammography system.

The Kassenärztliche Vereinigungen (regional Associations of Statutory Health Insurance Physicians) are inviting women aged 50-69 years for mammography screening and, slowly but surely, the appointment books of the centres that perform this early detection examination are filling.

Immobilisation of the female breast for diagnostic examination and biopsy is one of the prime foci of the Noras Company.

In September 2002, when Philippe Houssiau became President of Agfa's HealthCare Business Group, he quickly saw that the company possessed huge imaging technology and knowledge that could be focused on producing new products and solutions.

Cynthia E Keen discusses the controversy evoked by an ambitious 36-month digital mammography trial that has cost the US $26,000,000

Ballon Brachytherapy and effective drug combination.